[go: up one dir, main page]

Ko et al., 1998 - Google Patents

TGF-β1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression

Ko et al., 1998

View PDF
Document ID
583486905197806501
Author
Ko T
Yu W
Sakai T
Sheng H
Shao J
Beauchamp R
Thompson E
Publication year
Publication venue
Oncogene

External Links

Snippet

Transforming growth factor-beta 1 (TGF-β1) arrests intestinal epithelial cells (RIE-1 and IEC- 6) in the G1 phase of the cell cycle and inhibits cyclin D1 expression. This report describes experiments designed to elucidate the mechanism of cyclin D1 inhibition and to determine …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

Publication Publication Date Title
Ko et al. TGF-β1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression
US6617171B2 (en) Methods for diagnosing and treating autoimmune disease
Waters et al. Insulin-stimulated disassociation of the SOS-Grb2 complex
Rodriguez-Viciana et al. Phosphatidylinositol 3’kinase: one of the effectors of Ras
Clevenger Role of prolactin/prolactin receptor signaling in human breast cancer
US20050233991A1 (en) Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
US20060035849A1 (en) Methods and composition for modulating type I muscle formation using pgc-1 alpha
Braun et al. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation
JP2009527485A (en) Regulation of bone formation
JP2003512304A (en) Pharmaceutical composition and method using secretory frizzling-related protein
US11291706B2 (en) Methods for identification, assessment, prevention, and treatment of metabolic disorders using Slit2
Rehnmark et al. Differential adrenergic regulation of C/EBPα and C/EBPβ in brown adipose tissue
Dai et al. Rcho-1 trophoblast cell placental lactogens: complementary deoxyribonucleic acids, heterologous expression, and biological activities
US10429384B2 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
Jolivet et al. Regulation by the extracellular matrix (ECM) of prolactin‐induced αs1‐casein gene expression in rabbit primary mammary cells: Role of STAT5, C/EBP, and chromatin structure
Ko et al. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
US20080248475A1 (en) Methods and Compositions for Modulating Gluconeogenesis Using PGC-1
EP0897425A1 (en) Novel trio molecules and uses related thereto
EP1226279A1 (en) Modulation of neuroendocrine differentiation by protein 25.1
US20050084916A1 (en) Identification of the IkappaBNS protein and its products
WO2008033374A2 (en) Ocl-2a3 compositions and uses thereof
Liu The role of CREM/ICER transcription factors in bone
Crist et al. EGR-1 Prevents growth arrest by induction of c-myc
Beck Jr The roles of the pRb and p300 families in osteoblast differentiation
ROUSSET Connexin32 acts as a down regulator of growth of thyroid gland